000			01446 a2200445 4500
005			20250514195552.0
264		0	_c20040923
008			200409s 0 0 ita d
022			_a0048-7449
040			_aNLM _beng _cNLM
100	1		_aZeni, S
245	0	0	_a[Raynaud's phenomenon]. _h[electronic resource]
260			_bReumatismo _c
300			_a77-81 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAdolescent
650	0	4	_aAdrenergic alpha-Antagonists _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aCalcium Channel Blockers _xadministration & dosage
650	0	4	_aChild
650	0	4	_aConnective Tissue Diseases _xcomplications
650	0	4	_aCross-Sectional Studies
650	0	4	_aDiagnosis, Differential
650	0	4	_aFemale
650	0	4	_aFluoxetine _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLosartan _xtherapeutic use
650	0	4	_aMale
650	0	4	_aNifedipine _xadministration & dosage
650	0	4	_aPrazosin _xtherapeutic use
650	0	4	_aProstaglandins _xtherapeutic use
650	0	4	_aRaynaud Disease _xdiagnosis
650	0	4	_aScleroderma, Systemic _xcomplications
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use
650	0	4	_aSex Factors
700	1		_aIngegnoli, F
773	0		_tReumatismo _gvol. 56 _gno. 2 _gp. 77-81
999			_c15008431 _d15008431